Board Member
CurrentJavelin Biotech launched in the summer of 2019 with a team of scientists focused on developing solutions for specific challenges of drug discovery and development. Javelin integrates a microphysiological system (MPS), commonly referred to as “organ-on-a-chip,” with interactive computational software to help inform human pharmacokinetic (PK) predictions, a key measure in evaluating new drug candidates in preclinical research. The recently launched Liver Tissue Chips are easy to use and deliver insights pharmaceutical researchers need to build confidence and advance therapies towards the clinic. A broad platform of additional tissues and applications relevant to clinical research are in the pipeline.